Global Biospecimen Contract Research Services Market Report 2021
Friday, October 29, 2021
DUBLIN, Oct. 21, 2021 /PRNewswire/ -- The "Biospecimen Contract Research Services Market by Therapeutic Area, Type of Biospecimen, Type of Biospecimen for Non-Oncological Studies, Key Geographical Regions, Europe and Asia Pacific: Industry Trends and Global Forecasts, 2021-2030" report has been added to ResearchAndMarkets.com's offering.
https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
The "Biospecimen Contract Research Services Market" report features an extensive study on the companies offering research services related to biospecimens. The study underlines an in-depth analysis, highlighting the diverse capabilities of stakeholders engaged in this domain.
Over the last few decades, the field of biospecimen research has witnessed significant technological advancements resulting in the procurement of high quality biospecimens for molecular research purposes. In fact, new best practices and improved methods of procurement, processing and storage of biospecimens have also been introduced to the industry.
The pharmaceutical industry has seen a significant shift towards outsourcing the bioanalytical services to leverage cost-effective methods and overcome the existing capacity constraints. This shift is evident from the increase in partnership activity focused on expanding the existing capabilities of service providers and offering biospecimen procurement and analytical services.
Based on the prevalent trends, we believe that more developers and innovators are likely to rely on the contract research organizations in order to deal with the existing challenges and drive innovation in drug development, thereby, increasing the opportunities for these service providers in the foreseen future.
One of the key objectives of the report was to estimate the current market size and the growth opportunities in the biospecimen contract research services market, over the next decade. Based on different parameters, such as overall human biological sample market, share of commercial biobanks and share of biospecimen contract research service providers, we have provided informed estimates on the evolution of the market for the period 2021-2030.
An in-depth analysis of biospecimen contract research service providers, featuring four schematic representations
-- A grid analysis based on the year of establishment and type of
analytical services offered
-- A representation based on the therapeutic area and most active players
-- An analysis based on the company size and therapeutic area
-- Aworld map representation highlighting the regional distribution of
biospecimen research service providers, based on the locations of their
biorepositories.
Scope of the Report
Amongst other elements, the report includes:
-- A detailed review of the overall landscape of the companies that claim
to offer research services related to biospecimens, including analysis
based on a number of relevant parameters, such as year of establishment,
company size, location of headquarters, types of blood products offered
(plasma, serum, whole blood, blood cells and bone marrow), types of
human tissues offered (Formalin-Fixed Paraffin-Embedded, frozen tissue
and fresh tissue), types of biofluids offered (urine, saliva,
cerebrospinal fluid, swab, synovial fluid, others), types of other
biospecimens offered (fecal matter and nucleic acid), types of
analytical services offered (histological analysis, target validation,
tissue microarray, tumor tissue analysis and cell based assay), types of
samples offered (healthy and diseased samples), types of accreditations
received, and geographical reach (North America, Europe, Asia-Pacific
and Rest of the World).
-- A detailed competitiveness analysis of the biospecimen contract research
service providers based in different geographies offering services from
their own biorepository or through the network of biorepositories, based
on portfolio strength (in terms of number of biospecimens, number of
analytical services and number of samples offered), service strength (in
terms of number of accreditations and geographical reach), supplier
strength (in terms of years of experience in this field and company
size).
-- Tabulated profiles of key players offering a wide range of research
services for the biospecimens across North America, Europe and
Asia-Pacific. Each profile features a brief overview of the company,
details on its biospecimen related services offered, types of blood
products offered, types of human tissues offered, types of other
biospecimens offered, types of analytical services offered, types of
samples offered, geographic availability of the services, recent
developments and an informed future outlook.
-- An analysis of partnerships established in this domain since 2015,
covering the deals focused on the services related to biospecimens,
merger/acqusition, service agreement, service alliance, distribution
agreement, joint venture and other agreements.
-- A case study of the overall landscape of biospecimen procurement service
providers (commercial biobanks), based on a number of parameters, such
as year of establishment, company size, location of headquarters, types
of services offered (sample collection, sample processing, sample
logistic/transportation and sample storage), types of biospecimens
handled (biofluids, human cells and tissues), therapeutic area
(cardiovascular disorders, oncological disorders, neurological
disorders, infectious diseases and other therapeutic areas). In
addition, it presents a competitiveness analysis of the commercial
biobanks based on the availability of their respective biorepositories.
Key Questions Answered
-- Which are the leading contract researchers offering services related to
biospecimens?
-- Which are the most common types of blood products offered by the
biospecimen contract research service providers?
-- Where are the biorepositories owned by biospecimen contract research
service providers located?
-- Which are the most common type of services offered by the biospecimen
contract research service providers?
-- What type of services is offered by the commercial biobanks?
-- Which players are offering biospecimen related services through
collaborations?
-- How is the current and future market opportunity likely to be
distributed across key market segments?
Key Topics Covered:
1. Preface
2. Executive Summary
3. Introduction
4. Market Landscape
5. Company Competitiveness Analysis
6. Biospecimen Service Providers In North America: Company Profiles
7. Biospecimen Service Providers In Europe And Asia-Pacific: Company Profiles
8. Partnerships And Collaborations
9. Case Study: Market Landscape Of Commercial Biobanks
10. Key Insights
11. Market Forecast And Opportunity Analysis
12. Conclusion
13. Executive Insights
14. Appendix 1: Tabulated Data
15. Appendix 2: List Of Companies And Organizations
-- Accio Biobank Online
-- Akoya Biosciences
-- Allcyte
-- AMSBIO
-- Analytical Biological Services
-- ApoCell
-- Applied Immunology
-- Ardent-Clinical Research Services
-- Ascendance Biotechnology (acquired by BioIVT)
-- Asterand Bioscience (acquired by BioIVT)
-- ATCG
-- Atreide Biosamples
-- Audubon Bioscience
-- Aurora Health Care
-- Bay Biosciences
-- BIO|OPTIONS
-- BioChain Institute
-- Biognosys
-- BioIVT (formerly BioreclamationIVT)
-- BioKaizen
-- Biological Industries
-- Biological Specialty Company (acquired by BioreclamationIVT)
-- Biomedica CRO
-- Bioneer
-- BioPartners
-- Biopta (a part of ReproCell)
-- Biospecimen Solutions
-- Biostor Ireland
-- BioTools
-- Boca Biolistics
-- Brooks Life Sciences
-- UNC BioSpecimen Processing Facility
-- Capital Biosciences
-- CellCarta (formerly Caprion-HistoGeneX)
-- Clinical Biosamples & Research Services
-- Clinical Logistics
-- Clinical Trials Laboratory Services (CTLS)
-- Clinical OMICs
-- CliniSciences
-- Conversant Bio
-- Creative Bioarray
-- Cryoport
-- Cureline
-- Custom Science
-- Definiens
-- Delaware Health Information Network
-- Discovery Life Sciences
-- Doctors Pathology Services
-- Dx Biosamples
-- East West Biopharma
-- Eastern Biologix
-- Fidelis Research
-- Flagship Biosciences
-- Folio Biosciences
-- Fox Chase Cancer Center
-- Geneticist
-- Genohm (acquired by Agilent)
-- GLAS (acquired by Precision for Medicine)
-- Global BioClinical (GBC)
-- Gnosis
-- GR BioResearch
-- Great Lakes Health Connect (GLHC)
-- Helomics
-- HemaCare
-- HistoGeneX
-- Hoth Therapeutics
-- Infinity BiologiX
-- ICON
-- Indivumed
-- International Society for Biological and Environmental Repositories
(ISBER)
-- Institute of Molecular and Cell Biology (IMCB)
-- iProcess
-- iSpecimen
-- KAC
-- KamTek
-- Keystone Biologicals (acquired by BioIVT)
-- Los Rios Community Colleges District
-- Maricopa Integrated Health System (MIHS)
-- Marshall Medical Centre
-- Mayo Clinic
-- Medicover
-- MolecularMD
-- MT Group
-- myOnsite HealthCare
-- National BioService (NBS)
-- NeuCyte
-- Nexelis
-- Obio
-- Oxford BioDynamics (OBD)
-- Personalis
-- Phylogeny
-- PPA Research Group
-- Precision for Medicine (formerly Epiontis)
-- PrecisionMed
-- Precision Medicine Group
-- PrimeBioNet
-- ProMedDx (acquired by Precision for Medicine)
-- Promega
-- ProteoGenex
-- Q&T Research
-- QualTek Molecular Laboratories (acquired by Discovery Life Sciences)
-- REPROCELL
-- Reveal Biosciences
-- Samples Force
-- SampleSmart
-- Sanguine BioSciences
-- Sapien Biosciences
-- Science Exchange
-- Shanghai Outdo Biotech
-- Shanghai Zhangjiang Biobank
-- Sofia Bio (acquired by Discovery Life Sciences)
-- Sofia Tech Park
-- StemExpress
-- The Salk Institute
-- Trans-Hit Biomarkers (acquired by Brooks Life Sciences)
-- TriCore Reference Laboratories
-- TriMetis
-- TriStar Technology
-- UHN Biospecimen Services
-- Ultivue
-- US Biolab
-- Us4Cure
-- Viroclinics-DDL
-- VitroVivo Biotech
-- West-Atlantic Partners
For more information about this report visit https://www.researchandmarkets.com/r/b927qv
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
View original content:https://www.prnewswire.com/news-releases/global-biospecimen-contract-research-services-market-report-2021-301405877.html
SOURCE Research and Markets
|
|
|
|
|
 |
Skunk Works® and XTEND Expand Joint All Domain Command and Control for Advanced Mission Execution | Jan 22, 2026
|
|
Sup AI Sets New Benchmark Record with 52.15% on Humanity's Last Exam | Jan 22, 2026
|
|
Weekly Recap: 11 Tech Press Releases You Need to See | Jan 22, 2026
|
|
Trigent Partners with WeWork India to Expand its GCC Footprint | Jan 22, 2026
|
|
DEADLINE ANNOUNCED FOR 2026 NEW TOP-LEVEL DOMAIN APPLICATIONS | Jan 22, 2026
|
|
Exia Labs Brings Keystone to the U.S. Navy via DIU's Blue Object Management Challenge | Jan 22, 2026
|
|
Genpact Named a Leader in ISG Provider Lens(TM) 2025 for Insurance GCCs and Agentic AI Services | Jan 22, 2026
|
|
Marketing Evolution Announces New Investment Led by Insight Partners to Power AI-Ready Marketing Data for the Agentic Era | Jan 22, 2026
|
|
Glasswall Brings Defense-Level File Sanitization to Every Government Agency and Business Using Microsoft 365 | Jan 22, 2026
|
|
Altair HyperWorks 2026 Delivers Design and Simulation at Scale with AI | Jan 22, 2026
|
|
|
